to initiate its feasibility clinical study in Post Cardiac Arrest Syndrome.
ORIXHA obtains French Health Authority approval to initiate its feasibility clinical study in Post Cardiac Arrest Syndrome The OverCool clinical trial will enroll post cardiac arrest patients treated with ultra-rapid therapeutic hypothermia by the Vent2Cool device, a world premiere for a Total Liquid Ventilation therapeutic solution.